Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Receptor Tyrosine Protein Kinase ERBB 3 , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Receptor Tyrosine Protein Kinase ERBB 3 market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
By End-User / Application
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
By Company
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
Table of Contents
Part 1 Market Definition
1.1 Market Segment Overview
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market and Growth by Type
1.3 by End-Use / Application
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market and Growth by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD) by Vendors (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Vendors (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume (Volume) by Vendors (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Type (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume (Volume) by Type (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by End-Use / Application (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by End-Use / Application (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Regions (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Regions (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume (Volume) by Regions (2017-2019)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
5.2.1 North America
Figure North America Market Growth 2015-2018
5.2.2 Europe
Figure Europe Market Growth 2017-2019
5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
5.2.4 South America
Figure South America Market Growth 2017-2019
5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019
6 North America Market
6.1 by Type
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Type (2017-2019)
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by End-Use / Application (2017-2019)
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Regions (2017-2019)
Table North America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Regions (2017-2019)
7 Europe Market
7.1 by Type
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Type (2017-2019)
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Regions (2017-2019)
Table Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Regions (2017-2019)
8 Asia-Pacific Market
8.1 by Type
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Regions (2017-2019)
9 South America Market
9.1 by Type
Table South America Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Type (2017-2019)
Table South America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by End-Use / Application (2017-2019)
Table South America Receptor Tyrosine Protein Kinase ERBB 3 Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Regions (2017-2019)
10 Middle East & Africa Market
10.1 by Type
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Regions (2017-2019)
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) Forecast by Regions (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Regions (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) Forecast by Type (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3Market Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Bosch AstraZeneca Plc
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca Plc
12.2 AVEO Pharmaceuticals, Inc.
12.3 Etubics Corporation
12.4 F. Hoffmann-La Roche Ltd.
12.5 GamaMabs Pharma S.A.
12.6 GlaxoSmithKline Plc
12.7 Hanmi Pharmaceuticals, Co. Ltd.
12.8 ImmunoGen, Inc.
12.9 Kolltan Pharmaceuticals, Inc.
12.10 Merrimack Pharmaceuticals, Inc.
12.11 Merus B.V.
12.12 Novartis AG
12.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
12.14 Sihuan Pharmaceutical Holdings Group Ltd.
12.15 Sorrento Therapeutics, Inc.
12.16 Symphogen A/S
12.17 Takis S.r.l.
13 Overview of Industry Development (COVID-19)
13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)
14 Research Conclusion